V
Veronica Tisato
Researcher at University of Ferrara
Publications - 89
Citations - 3009
Veronica Tisato is an academic researcher from University of Ferrara. The author has contributed to research in topics: Cytokine & Disease. The author has an hindex of 22, co-authored 84 publications receiving 2373 citations. Previous affiliations of Veronica Tisato include University of Padua & Imperial College London.
Papers
More filters
Journal ArticleDOI
Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.
TL;DR: It is suggested that MSC have the ability to form a cancer stem cell niche in which tumor cells can preserve the potential to proliferate and sustain the malignant process.
Journal ArticleDOI
COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
Donato Gemmati,Barbara Bramanti,Maria Luisa Serino,Paola Secchiero,Giorgio Zauli,Veronica Tisato +5 more
TL;DR: SARS-CoV-2 has a strong interaction with the human ACE2 receptor, which plays an essential role in cell entry together with transmembrane serine protease 2 (TMPRSS2), and several genes involved in inflammation are located on the X-chromosome, which also contains high number of immune-related genes responsible for innate and adaptive immune responses to infection.
Journal ArticleDOI
Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase
John Mitchell,Praveen Paul,Han-Jou Chen,Alex G. Morris,Miles Payling,Mario Falchi,JJ Habgood,Stefania Panoutsou,Sabine Winkler,Veronica Tisato,Amin Hajitou,Bradley N. Smith,Caroline Vance,Christopher Shaw,Nicholas D. Mazarakis,Jacqueline de Belleroche +15 more
TL;DR: A unique mutation in the D-amino acid oxidase gene (R199W DAO) associated with classical adult onset familial amyotrophic lateral sclerosis (FALS) in a three generational FALS kindred is reported, after candidate gene screening in a 14.52 cM region on chromosome 12q22-23 linked to disease.
Journal ArticleDOI
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.
TL;DR: An updated overview about the state of the art of the clinical evaluation of MDM2/X inhibitor compounds with a special attention to hematological malignancies and to the potential for the management of pediatric cancers is given.
Journal ArticleDOI
Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease.
TL;DR: Clinical use of MSC in stem cell transplantation as a prophylaxis rather than treatment of GVHD is supported, and a xenogenic model testing the ability of umbilical cord blood-derived MSC (UCB-MSC) to prevent and/or treat GV HD is designed.